$ Value
$0
Shares
952,250
Price
$0
Filed
Feb 5
Insider
Name
Ali Faraz
Title
Chief Executive Officer
CIK
0001667937
Roles
Transaction Details
Transaction Date
2026-02-03
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
952,250
Footnotes
Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock. | The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2026, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested. | Includes 369,875 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. | Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested.
Filing Info
Ali Faraz's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-17 | TNYA | ▼ | $4K |
| 2026-02-17 | TNYA | ▼ | $3K |
| 2026-02-17 | TNYA | ▼ | $3K |
| 2026-02-03 | TNYA | A | $0 |
| 2026-02-03 | TNYA | A | $0 |
| 2025-11-17 | TNYA | ▼ | $4K |
| 2025-08-18 | TNYA | ▼ | $7K |
| 2025-08-18 | TNYA | ▼ | $5K |
| 2025-08-18 | TNYA | ▼ | $6K |
| 2025-05-16 | TNYA | ▼ | $1K |
Other Insiders at TNYA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Ali Faraz
Chief Executive Officer
|
— | $10K | 2026-02-17 |
| COLUMN GROUP III GP, LP | — | $5.9M | 2026-02-25 |
|
Tingley Whittemore
Chief Medical Officer
|
— | $3K | 2026-02-17 |
|
Higa Tomohiro
SVP, Finance
|
— | $2K | 2026-02-17 |